Atlas Trials

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Clinical trial NCT04995159 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04995159
Sponsor
Lepu Medical Technology (Beijing) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Heart Disease
Start date
2021-09-01
Primary completion
2026-01-01
Enrollment
2150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.